The Type II diabetes prescription medicine Onglyza has been linked to serious health consequences, including congestive heart failure. If you or a loved one have suffered from heart failure or similar issues after using Onglyza or another medicine with saxagliptin in it, you may be entitled to file a claim for compensation. Fibich, Leebron, Copeland & Briggs and our Onglyza attorneys are here to help you discover your rights, create a claim against AstraZeneca, and fight for you in court, if need be.
Onglyza was approved by the Food and Drug Administration (FDA) in 2009, but health experts and cardiologists alike quickly challenged the approval by conducting in-depth, independent studies of the medicine. It was found through multiple avenues of research that Onglyza can cause serious illnesses or death. The FDA later agreed to place warning labels on the medicine’s packaging and placed a warning in the New England Journal of Medicine.
Despite the extensive research findings and the FDA warning, AstraZeneca took no steps to warn the public. There is even reason to believe the pharmaceutical giant attempted to prevent the findings from being disseminated. In either situation, the liability for the harm caused to diabetes patients who were prescribed Onglyza falls upon AstraZeneca.
Filing an Onglyza injury claim against AstraZeneca pits you against a powerful corporation that frequently defends itself from such accusations. Give yourself the advantage and legal abilities needed by retaining the services of our pharmaceutical liability attorneys from Fibich, Leebron, Copeland & Briggs. For decades, we have been taking on Big Pharma for individuals — and winning. We are not intimidated by their tactics, and we never back down when our client’s wellbeing is on the line.
© 2020 All Rights Reserved.
1150 BISSONNET ST
HOUSTON, TX 77005